AKT signaling pathway is one of the most critical and extensively investigated signaling pathways. It is the central ...

InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, is presenting preclinical data at 15th Annual World ADC ...

A new study identifies key genetic vulnerabilities in glioblastoma stem cells, revealing subtype-specific dependencies that ...

Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and Drug Administration ...

Intercellular adhesion can be mediated by adherens junctions, tight junctions and desmosomes, whereas cells can interact with extracellular matrix molecules through focal adhesions.

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $13.00.

Verastem initiated the rolling NDA submission in May. Credit: Jo Panuwat D via Shutterstock. Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on VSTM stock, giving a Buy rating on October 18. Graig ...